title: The Cdx-2 polymorphism in the VDR gene is associated with increased risk of cancer: a meta-analysis.
abstract: The Cdx-2 polymorphism in VDR gene has been extensively investigated for association with cancer risk, however, results of different studies have been inconsistent. The objective of this study is to assess the relationship of the Cdx-2 polymorphism in VDR and cancer risk by meta-analysis. All eligible case-control studies were searched in Pubmed, Embase, CNKI and Wanfang databases. Odds ratios (OR) with the 95 % confidence intervals (CI) were used to assess the association. A total of 12,906 cases and 13,700 controls in 18 case-control studies were included. The results indicated that the AA homozygote carriers had a 16 % increased risk of cancer, when compared with the homozygote GG and heterozygote AG (OR = 1.16, 95 % CI 1.05-1.29 for AA vs. GG+AG). In the subgroup analysis by ethnicity, significant elevated risks were associated with AA homozygote carriers in Caucasians (OR = 1.16, 95 % CI 1.01-1.33, and P = 0.04) and African Americans (OR = 1.31, 95 % CI 1.07-1.61, and P = 0.01). In the subgroup analysis by cancer types, the polymorphism was associated with increased risk of breast cancer (OR = 1.23, 95 % CI 1.04-1.46, and P = 0.02). This meta-analysis suggested that the Cdx-2 polymorphism of VDR gene would be a risk factor for cancer. To further evaluate gene-to-gene and gene-to-environmental interactions between polymorphisms of VDR gene and cancer risk, more studies with large groups of patients are required.
authors: West China Medical School/West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
authors: Jin
authors: J
authors: Huang
authors: Jichong
authors: J
authors: Huang
authors: Yaxian
authors: Y
authors: Ma
authors: Haichuan
authors: H
authors: Wang
authors: Jiqiao
authors: J
authors: Yang
authors: Tianyuan
authors: T
authors: Xiong
authors: Liang
authors: L
authors: Du
mesh_terms: D000483:Alleles; D000071616:CDX2 Transcription Factor; D016022:Case-Control Studies; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D018398:Homeodomain Proteins / Q000235:genetics*; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000235:genetics*; D016017:Odds Ratio; D011110:Polymorphism, Genetic; D017594:Publication Bias; D018167:Receptors, Calcitriol / Q000235:genetics*; D012306:Risk; D015534:Trans-Activators / Q000235:genetics*
chemical_list: D000071616:CDX2 Transcription Factor; D018398:Homeodomain Proteins; D018167:Receptors, Calcitriol; D015534:Trans-Activators
references: Mol Biol Rep. 2012 Jun;39(6):6471-8
references: 22290287
references: Mol Biol Rep. 2013 Jan;40(1):171-6
references: 23143180
references: Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1708-17
references: 21693626
references: Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2566-71
references: 18086759
references: N Z Med J. 2012 Jun 08;125(1356):47-51
references: 22729058
references: Int J Cancer. 2008 Nov 1;123(9):2170-9
references: 18709640
references: Clin Cancer Res. 2008 May 15;14(10):3223-9
references: 18483391
references: Eur J Cancer. 2009 Dec;45(18):3271-81
references: 19615888
references: Breast Cancer Res. 2008;10(2):R31
references: 18419802
references: Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):16-24
references: 23129590
references: Mol Biol Rep. 2013 Feb;40(2):1835-41
references: 23096092
references: Eur J Clin Pharmacol. 2007 Nov;63(11):997-1005
references: 17882409
references: Carcinogenesis. 2008 Sep;29(9):1788-93
references: 18628249
references: Eur J Endocrinol. 2011 Jan;164(1):75-82
references: 21051524
references: Breast Cancer Res. 2012 Apr 04;14(2):R58
references: 22480149
references: Cancer Res. 2005 Jun 15;65(12):5470-9
references: 15958597
references: Carcinogenesis. 2007 Feb;28(2):390-7
references: 16950800
references: Cancer Res. 2009 Mar 1;69(5):1885-91
references: 19223536
references: Allergy. 2011 Feb;66(2):197-205
references: 20880211
references: Prostate. 2007 Jun 15;67(9):911-23
references: 17440943
references: Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2239-45
references: 17119052
references: Mol Biol Rep. 2012 Feb;39(2):831-7
references: 21584699